Business
Mesoblast now expects to release Ryoncil ruling on Monday – Stockhead
Mesoblast is in a trading halt, but doesn’t expect to announce the FDA’s decision on Ryoncil until Monday Approval of the stem cell treatment to treat pediatric…
Link copied toclipboard
- Mesoblast is in a trading halt, but doesn’t expect to announce the FDA’s decision on Ryoncil until Monday
- Approval of the stem cell treatment to treat pediatric graft-versus-host disease would be transformative for the company
- A reason for the delay wasn’t given
Mesoblast (ASX:MSB) shareholders have a few more sleepless nights ahead of them.
The closely watched biotech went into a trading halt this morning in relation to the US Food and …
Continue Reading
-
Business21 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News24 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses
-
Noosa News16 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Noosa News23 hours agoNick Cave and The Bad Seeds Are Bringing Their ‘Wild God’ Tour to Australia and New Zealand in 2026